- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 481.27B sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.18M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.19M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $1.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.18M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.67M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.18M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.95M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.67M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.22M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 429.92B sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $47.19K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.37M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $5.02M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $6.76M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.86M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.2M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | −$13 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $132 |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $119 |